1986
DOI: 10.1097/00132582-198606000-00003
|View full text |Cite
|
Sign up to set email alerts
|

Maternal and Fetal Metabolic Effects of Prolonged Ritodrine Infusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
2

Year Published

1990
1990
2009
2009

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 0 publications
1
8
2
Order By: Relevance
“…In that situation, direct actions of ritodrine within the fetus would be additional to those resulting from altered placental nutrient fluxes caused by disturbances to maternal metabolic homeostasis in the early stages of drug administration. During our present investigation, there were no changes in maternal metabolism comparable to those observed during ritodrine administration to the ewe (5).…”
Section: Discussioncontrasting
confidence: 57%
See 1 more Smart Citation
“…In that situation, direct actions of ritodrine within the fetus would be additional to those resulting from altered placental nutrient fluxes caused by disturbances to maternal metabolic homeostasis in the early stages of drug administration. During our present investigation, there were no changes in maternal metabolism comparable to those observed during ritodrine administration to the ewe (5).…”
Section: Discussioncontrasting
confidence: 57%
“…Hematocrits were determined using a microhematocrit centrifuge (Hawksley, Sussex, UK). Blood glucose, lactate, and the hormones insulin and glucagon were determined by methods reported previously (5,6). FFA were determined on 100-pL samples of fetal plasma by a microcolorimetric method using Wako NEFA kits (Alpha Laboratories, Fareham, Hants, UK) after first diluting both the reagents to half the recommended concentration.…”
Section: Animals and Theirpreparationmentioning
confidence: 99%
“…They suggest that there is a link between chronic beta adrenergic agonist use and PPCM, and advocate close evaluation of cardiac function of all pregnant women receiving long-term beta sympathomimetic tocolysis. In a series of 15 women on ritodrine tocolysis, 11 of them developed ECG changes consistent with myocardial ischaemia [94]. The authors postulate that silent ischaemia could contribute to the cardiomyopathy that has been reported after prolonged ritodrine treatment.…”
Section: Prolonged Tocolysis As a Risk Factormentioning
confidence: 99%
“…Prolonged tocolysis refers to the use of tocolytic agents for a period greater than four weeks [94]. Pulmonary oedema occurring in the peripartum period has long been associated with the administration of tocolytic drugs, which include terbutaline, ritodrine, salbutamol, isoxsuprine and magnesium sulphate [95].…”
Section: Prolonged Tocolysis As a Risk Factormentioning
confidence: 99%
“…In 1979, ritodrine was acknowledged as safe and effi cient for the treatment of preterm labor [2], However, numerous maternal [2] and fetal [3] side effects have been attributed to the drug, which, due to its low molec ular weight, 287 dalton, was reported to cross the mater nofetal barrier [4] and to affect placental metabolism in vitro [5]. Ritodrine transfer across the placenta was pre viously studied in vivo in humans [4], However, accu rate transfer measurements were difficult to perform, and evidence for ritodrine accumulation in placental tis sue was not substantiated.…”
Section: Introductionmentioning
confidence: 99%